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Sequential first pass radionuclide angiocardiography can
be performed in rapid succession using gold-195m be-
cause of its low radiation dose and short half-life (30.5
seconds). In 25 patients with known or suspected coro-
nary artery disease, first pass studies with gold-195m
were obtained using a computerized multicrystal gamma
camera at rest (n = 29), at the end of each 3 minute
stage of exercise (n =25) and immediately after exercise
(n = 23). In 13 patients, assessment of left ventricular
function during exercise with gold-195m was combined
with thaIlium-201 stress scintigraphy.
Left ventricular ejection fraction at rest assessed with
technetium-99mand gold-195m correlated well(r =0.93).
In addition, repeat left ventricular ejection fractions at
rest with gold-195m correlated closely (r =0.96). Com-
paring peak exercise left ventricular ejection fraction
Technetium-99m is currently the radionuclide of choice for
first pass radionuclide angiocardiography. However, its rel-
ative long half-life (6 hours) and patient dosimetry consid-
erations pose some practical limitations to this clinical use
of the radiotracer. For example, using technetium-99m la-
beled pharmaceuticals that are cleared primarily by the kid-
neys or the reticuloendothelial system, the total number of
studies that can be performed in sequence and the dose per
study are limited (three studies and 10 mCi, respectively).
In addition, the minimal time interval between sequential
studies using these radiopharmaceuticals is longer than de-
sirable (especially during exercise) and should be at least
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with ejection fraction at rest, abnormal left ventricular
reserve was found in 20of 25 patients. Various abnormal
patterns of left ventricular ejection fraction response
were noted, showing the diagnostic potential of serial
exercise angiocardiography. ThaIlium-201 myocardial
images, obtained on a single crystal gamma camera after
multiple gold-195m injections, were all of good diag-
nostic quality and were abnormal in 10 of 13 patients.
Thus, multiple high count rate first pass studies can
be obtained with gold-195m during and after exercise,
allowing serial study of physiologic changes in left ven-
tricular function during exercise. ThaIlium-201 myo-
cardial imaging can be performed using the same ex-
ercise test, providing direct comparison of myocardial
function and perfusion.
10 minutes. Recently, we demonstrated (I) the feasibility
of performing rapid sequential first pass radionuclide an-
giocardiography in experimental animals using a new short-
lived (30.5 seconds) radiotracer, gold-195m. This radio-
nuclide is the daughter of the long-lived parent mercury-
195m and can be obtained from a shielded tabletop gen-
erator. The high yield of gold-195m allows performance of
excellent quality high countrate first pass studies.
The present study reports our initial results with this
radionuclide in patients with coronary artery disease eval-
uated during exercise. Use of this short-lived radiotracer
allows for rapid sequential assessment of left ventricular
ejection fraction by first pass radionuclide angiocardiogra-
phy at rest and during each stage of exercise. This provides
an important means of gaining insight into the physiologic
changes in exercise cardiac performance in individual pa-
tients. Because of the short half-life of gold-195m, exercise
thallium-201 myocardial perfusion imaging can be per-
formed using the same exercise test employed in the as-
sessment of left ventricular function. The present study dem-
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onstrates the feasibility of combined serial function and
perfusion studies.
Methods
Study patients. Twenty-nine patients with an age range
of 41 to 71 years were included in this study. Twenty-five
of the 29 patients had coronary artery disease documented
by one or more of the following: coronary angiography
within 6 months of the study (n = 9), transmural myocardial
infarction (n = 15) or typical angina pectoris with ischemic
exercise treadmill response (n = 8). Four patients had an
atypical chest pain syndrome. All 29 patients were in func-
tional class II or III according to criteria of the New York
Heart Association. The patients were selected on the basis
of their willingness to participate in the research protocol
and their availability at the time of generator shipment (see
later). Informed written consent was obtainedfrom all patients.
Mercury-195m/gold-195m generator. Eight prototype
table top mercury-195m/gold-195m generators were used
for this study, supplied on a limited basis by Byk-Mallinck-
rodt (petten , Holland) . The generator has been described
previously (1). In brief, it consists of a lead housing con-
taining a glass column on which the parent mercury-195m
(half-life of 41.6 hours) is absorbed on inorganic material.
The column is flushed with aqueous sodium-thiosulfate/so-
dium nitrate eluent (supplied by Byk-Mallinckrodt) .
Careful quality control and analysis of performance of
each individual generator were performed before it was used
with patients . First , the generator was flushed with at least
40 ml of eluent to wash off the mercury-195m and mercury-
195 freed from the column by radioautolysis . Subsequently,
the eluate (2 ml) was measured in a standard dose calibrator
(model CRC-17, Capintec) to determine the amount of gold-
195m obtained and the breakthrough of mercury-195m . As
previously described , absolute calibration was performed
using a standard reference source of selenium-75 . Dose
calibrator readings for mercury-195m and gold-195m were
corrected on the basis of these absolute calibrations. Before
the beginning of a patient study , the activity of gold-195m
in the eluate was measured 15 seconds after the start of
elution, because this represents the approximate time at
which the radioactive bolus will be injected. The amount
of mercury-195m breakthrough in the eluate was measured
15 minutes after elution.
We calculated estimated human radiation doses based
on biodistribution studies of mercury-195m and its de-
scendants , gold-195m, mercury-195 and gold-195 in ani-
mals at 48 hours after injection (1). The target organs for
mercury 195m and its descendants are the kidneys , which
receive 0 .017 rad//LCi of mercury-195m. To limit the ra-
diation dose to the kidneys to 5 rads (as recommended by
U.S. Food and Drug Administration guidelines) (2), the
maximal amount of mercury-195m that can be injected in
an individual patient per study should not exceed 295 /LCi .
Thus , by knowing the amount of mercury-195m break-
through in the eluate , the maximal number of injections that
can be administered to an individual patient can be calcu-
lated for each individual generator.
After initial animal studies (1) , the sterile and pyrogen-
free prototype generators were approved for use in patients
by the Yale-New Haven Hospital Radioisotope and Radio-
active Drug Research Committees; the protocol also was
approvedby the Institutional Human InvestigationCommittee.
Exercise protocol. Before the exercise study, the pa-
tients were familiarized with the exercise imaging laboratory
and the experimental protocol. The electrocardiogram was
monitored during exercise using a 4 lead system (Hewlett-
Packard, 1500A). Heart rate, sphygmomanometric blood
pressure and electrocardiograms were obtained at rest before
exercise and once every minute during exercise. Exercise
was performed on an upright bicycle ergometer (Quinton
Instruments, model 884), with the patient sitting in front of
the detector , which was rotated from the usual orientation.
The patient pedalled at a constant speed beginning with a
load of 150 kpm/min. Every 3 minutes , the load was in-
creased by 150 kpm/min. The end points of exercise were
defined as follows: onset of typical angina , 2 mm or greater
horizontal ST segment depression in an electrocardiographic
lead that was normal at rest , life-threatening arrhythmias ,
hypotension , severe fatigue or attainment of target heart
rate. After exercise , heart rate, blood pressure and the elec-
trocardiogram were monitored at 3 minute intervals until
these variables had returned to pretest levels .
First pass radionuclide angiocardiography. First pass
radionuclide angiocardiography was performed with a com-
puterized multicrystal scintillation camera (Baird-Atomic
System-77). The method for first pass radionuclide angio-
cardiography employed in our laboratory previously has
been standardized and validated using technetium-99m (3).
All patients had an 18 gauge, 1 inch (2.54 ern) polyethylene
catheter placed in a large antecubital vein for radionuclide
injection (described later). Subsequentl y, the lead-shielded
mercury-195m/gold-195m generator was placed approxi-
mately 30 cm from the injection site and adjacent to the
crystal surface of the gamma camera to minimize scatter
emanating from the generator. At least 15 minutes were
allowed to pass between catheter placement and the first
radionuclide injection to minimize the effect of increased
sympathetic tone associated with venipuncture and prestudy
anxiety.
Validation studies at rest. The first 18 patients had a
rest study with 15 mCi of technetium-99m-diethylenetri-
aminepentaacetic acid (DTPA) using previously described
techniques (3). After a period of approximately 20 minutes ,
the gold-195m generator was eluted five times to wash off
the excess of mercury-195m , mercury-195 and gold-195 .
Subsequently , two rest studies separated by 2 to 3 minute
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intervals were performed using gold-195m in 29 patients.
In five patients, multiple rest studies (three in four patients,
six in one patient) using gold-195m were performed at I
minute intervals. These rest studies were performed with
the patient sitting in an upright position on the bicycle er-
gometer. The patient was oriented in the anterior position
with the detector of the multicrystal camera vertical and
directly in front of the chest. The feet were placed on the
bicycle pedals in a position identical to that employed during
the subsequent exercise study.
For the first pass studies using gold-195m, the patients
catheter in the antecubital vein was connected to the outlet
of the column by a 3 ml extension tube filled with normal
saline solution. The generator was flushed rapidly with 2
ml of eluent introducing the eluate directly into the catheter.
First pass radionuclide angiocardiography was performed in
the anterior position by flushing the dose as rapidly as pos-
sible with 20 cc of normal saline solution contained in a
separate syringe attached to the extension tube by a three-
way stopcock. This technique is identical to the one em-
ployed routinely in our laboratory for technetium-99m. The
time interval between elution of the generator and rapid
injection was approximately 7 to 10 seconds.
Exercise studies. Twenty-five patients had gold-195m
first pass angiocardiography during multiple stages of ex-
ercise. During exercise, first pass angiocardiography was
repeated during the last 15 seconds of each 3 minute exercise
stage. Within less than I minute of the termination of ex-
ercise, an additional first pass study was performed. This
latter study was obtained with the patient pedaling slowly
against no resistance.
Combined stress thallium-201 myocardial perfusion
imaging and gold.195m left ventricular function study.
The potential effect of gold-195m injections (or mercury-
195m breakthrough) on thallium-20 I imaging was assessed
as follows. Two patients received a single injection of eluate
containing a known amount of mercury-195m. Five minutes
later, a 5 minute Image of the cardiac region in the left
anterior oblique position was obtained using a single crystal
gamma camera equipped with an all purpose parallel-hole
collimator. The energy window was set over 80 keY. From
the collected counts, the count rate/min per /-LCi of mercury-
195m was determined.
In 13 patients, the efficiency of performing combined
myocardial perfusion and left ventricular function studies
from a single exercise test was evaluated employing thal-
lium-20 I and gold-195m. Two mCi of thallium-20 I was
injected in the intravenous line when it appeared that the
patient was approaching the end point of exercise. The pa-
tient was then encouraged to continue exercising for at least
I minute more. After completion of the gold-195m first pass
studies as described, myocardial imaging was begun within
less than 5 minutes of the end of exercise. Imaging was
performed using a single crystal gamma camera (General
Electric 400T), equipped with an all purpose parallel-hole
collimator interfaced with a dedicated microcomputer (STAR,
General Electric). The energy window (20%) was set over
80 keY. Images were obtained for a preset time (10 minutes)
in the anterior, left anterior oblique and left lateral positions.
Delayed imaging was performed for identical time per view
as for the immediate postexercise study 3 to 4 hours after
the initial study. Background-subtracted images were dis-
played on white and black Polaroid film and were analyzed
qualitatively by visual inspection.
Processing first pass studies. The scintillation data ob-
tained of the transit of the bolus through the central circu-
lation were recorded at 50 ms/frame for the rest studies and
at 25 ms/frame for the exercise studies and stored in com-
puter memory. The pulse height analyzer settings of the
multicrystal were adjusted for the photon energy of the
radiotracer used. For the 262 keY photons from gold-195m,
the settings were window 50, bias 8 and lower level 20; for
the 140 keY photons from technetium-99m, the settings
were window 30, bias 6 and lower level 10. Field uniformity
correction for studies with gold-195m was performed using
a flood source containing mercury-203 (279 keY). A cobalt-
57 flood source (123 keY) was employed for studies with
technetium-99m. The data were corrected for the decay of
radionuclide for processing of the first pass studies using
gold-195m. Subsequent processing was performed as de-
scribed previously (3). A background-corrected time-activ-
ity curve (summed representative cycle) was generated from
an area of interest over the left ventricle. Left ventricular
ejection fraction was then calculated in the usual manner:
end-diastolic counts - end-systolic counts -i- end-diastolic
counts.
The lower limit of normal for left ventricular ejection
fraction at rest in our laboratory is 55% (4). On the basis
of results of previous reproducibility and variability studies
in our laboratory, an absolute change of ejection fraction
between two studies greater than 5% is considered to be a
significant and nonrandom change (5). In patients with left
ventricular ejection fraction at rest less than 75%, the normal
left ventricular response to exercise, on the basis of one at
rest and one peak exercise value, is defined as an absolute
increase of greater than 5% in left ventricular ejection frac-
tion. Regional wall motion was analyzed qualitatively by
superimposition of the end-diastolic perimeter on the end-
systolic image of the left ventricle (5).
Statistical methods. Data are expressed as the mean ±
standard deviation. Comparison of radionuclide data at rest
was made by a paired t test. Regression equations and cor-
relation coefficients were derived by standard formulas.
Results
Mercury-195m/gold-195m generator. The eight gen-
erators used for the present study contained 169 ± 26 mCi
of mercury-195m on the day of use. The activity of gold-
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195m obtained at 15 seconds after elution of these five
generators ranged from 37 to 16 mCi (mean 23 ± 8). The
yield of gold-195m at the time of elution was 39 ± 6%
(expressed as percent of gold-195m activity on the gener-
ator). The mercury-195m breakthrough/2 ml of eluate ranged
from 5 to 50 /-LCi (mean 32 ± 12). Therefore, in order not
to exceed a dose of 5 rads to the kidney, or a total of 295
/-LCi of mercury-195m (see previously), the total number of
sequential injections permitted per patient ranged from 6 to
59 (mean 10 ± 4).
Gold-195m first pass studies. All first pass studies ob-
tained with gold-195m were of excellent technical quality,
indistinguishable from those with technetium-99m (Fig. I).
There was good temporal separation of the right and left
heart phases of the first transit of the radioactive bolus through
the central circulation. Visually, the images with gold-195m
were comparable with those obtained with technetium-99m.
For a total of 166 gold-195m studies at rest and exercise,
the mean count rate acquired in the whole field of view,
uncorrected for decay during the left ventricular phase of
the bolus, was 211,128 ± 13,27l!second. The mean count
rate in the end-diastolic region of interest over the left ven-
tricle, decay- and background-corrected was 9,326 ± 1,056
counts. These count rates are equal to or slightly greater
than those obtained with 15 mCi of technetium-99m: 182,462
± 12,260 counts/second in the whole field of view during
the left ventricular phase and 4,260 ± 728 counts in the
end-diastolic region of interest over the left ventricle. The
background build-up during sequential first pass studies us-
ing gold-195m was minimal, ranging from 3 to 12% in the
end-diastolic left ventricular region of interest. The back-
ground activity is mainly from mercury-195m accumulation
in liver and kidneys.
Rest technetium-99m and gold-195m studies. Left
ventricular ejection fractions at rest assessed with techne-
tium-99m-DTPA and gold-195m correlated well (r = 0.93)
in the 18 patients who had both studies. The absolute mean
interstudy difference was 4 ± 4%. Mean left ventricular
ejection fraction with technetium-99m was 47 ± 14% and
with gold-195m, 47 ± 14%.
Repeat left ventricular ejection fraction at rest determined
by consecutive gold-195m studies also corresponded closely
(r = 0.96) in 29 patients. The absolute mean interstudy
difference was 4 ± 2%. Mean left ventricular ejection frac-
tion was 50 ± 14 and 50 ± 14%, respectively. In the five
patients who had multiple determinations of left ventricular
ejection fraction at rest with gold-195m at I minute inter-
vals, the mean absolute interstudy difference between con-
secutive studies was 3 ± 0.7%.
Exercise gold-195m studies. The mean exercise dura-
tion was 9.6 ± 2 minutes. Twenty-one patients exercised
to symptom-limited fatigue. Four patients discontinued ex-
ercise because of angina. Eight patients (including three with
angina) had an ischemic electrocardiographic response (:2:
I mm horizontal ST segment depression in a lead that was
normal at rest). Comparing mean rest ejection fraction with
peak exercise, abnormal exercise left ventricular reserve was
demonstrated in 20 of 25 patients. In this small number of
patients, various abnormal patterns (Fig. 2, Table I) were
observed, illustrating the diagnostic potential of serial stud-
ies during exercise. In 12 of the patients with an abnormal
functional response and in 4 of those with a normal response,
REST I
72 %
STAGE 2
49%
REST 2
' \1-I. "
71%
STAGE 3
53%
STAGE I
POST-EX
73%
Figure 1. Serial first pass radionuclide angiocar-
diography with gold-195m in Patient 21. The end-
systolic Images are superimposed over the end-
diastolic perimeter. High quality images are ob-
tamed at rest. at the end of each stage of exercise
and within I minute of termination of exercise.
Calculated left ventncular ejection fraction is dis-
played below each image. The patient experienced
angina pectoris during stage 3 of exercise, associ-
ated with 2 mm of ST segment depression. Left
ventncular ejection fraction decreased progres-
sively during exercise; within I minute after ter-
mination of exercise (POST-EX) it had returned to
baseline value.
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Figure 2. Examples of patterns (A, 8, C and D) of
abnormal left ventricular reserve observed in 20 of 25
patients, Theshaded zone indicates the anticipated var-
iability of 5% absolute in either direction of left ven-
tricular ejection fraction at rest. Changes beyond this
zone are significant changes . Left ventricular ejection
fraction at rest. at the endof each stage of exercise and
Immediately after exercise (lPE) is shown. The exercise
level is indicated askpm/min. Pattern A, Initial increase
inleft ventricularejectionfractionfollowed byadecrease
in ejection fraction compared with maximal value (four
patients). Pattern 8, Nochange In left ventricular ejec-
tion fraction during exercise(eight patients). Pattern C,
No change in left ventricular ejection fraction duringthe
initial submaximal phases of exercise followed by a de-
crease (three patients). Pattern D, Progressive decrease
in ejection fraction during exercise (five panents).
left ventricular ejection fraction immediately after exercise
was significantly greater (> 5%) than at rest. Mean left
ventricular ejection fraction immediately after exercise was
57 ± 14% compared with 50 ± 12% at rest (p < 0,01).
Figure I shows images of a representative example of ex-
ercise studies using serial gold-195m injections.
Thallium-2Ot imaging. The multiple gold-195m first
pass studies before myocardial imaging did not affect the
diagnostic quality of analog thallium-201 images. Never-
theless, there was measureable background activity after the
administration of eluate in the 80 keV thallium window,
originating from mercury-195m breakthrough accumulated
in the kidneys and liver. We measured 380 counts/min in
the whole field of view per p.C1 of mercury-195m injected.
This background activity is approximately stable over a 3
to 4 hour period, Figure 3 shows excellent quality thallium-
201 images obtained in a patient who received seven injec-
tions of gold-195m. Figure 4 compares a thallium-20 I im-
age. after a total of 12 injections and a total of 250 p.Ci of
mercury-195m administered. to that obtained in the same
patient after a routine thallium-20 I stress test.
The thallium-20I images were of good diagnostic quality
in all 13 patients. In three patients with atypical chest pain,
the images were entirely normal, both immediately after
exercise and at delayed imaging. The regional wall motion
on the exercise ventriculograms in these patients was also
normal. The remaining 10 patients had abnormal thallium
images showing evidence of either myocardial infarction or
exercise-induced myocardial ischemia or both. In all 10
patients. regional left ventricular wall motion was abnormal
during exercise at the anatomic location of the thallium-20 I
perfusion defect.
Discussion
This study demonstratesthe feasibility of performing rapid.
sequential determination of left ventricular ejection fraction
using gold-195m in patients and is a continuation of our
previous work with this radionuclide in animals (I) , This
new radionuclide allows monitoring of rapid changes in left
ventricular function using the first pass technique during
interventions such as upright exercise ,
Comparison of gold-195m and technetium-99m first
pass studies. The patient first pass studies obtained with
gold-195m were of high technical quality and indistinguish-
able from studies usually obtained with technetium-99m in
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Table 1. Left Ventric ular Eject ion Fraction (%) Determined by Gold-195m First Pass Angio graphy at Rest. Dunng Various Stages of
Exercise and Dur ing Recovery Immediately After Termination of Exerc ise in 25 Patients
Pattent R1 Rz R Mean EXI EXz EX) EX. EXs IPE EX Pattern TI-201
1* 55 52 54 59 60 57 N
2 47 51 49 60 62 67 N TO
3 52 48 50 61 56 72 N
4 60 67 63 69 72 82 78 76 80 N N
5 60 61 60 65 61 71 76 N N
6* 39 42 40 51 35 59 A
7* 39 38 39 47 42 50 A
8* 24 26 25 30 31 29 38 A PO
9 60 63 61 65 66 62 63 73 A TO
10* 31 35 33 31 38 B
11 * 44 38 41 37 37 37 54 B
12* 45 40 43 41 42 54 B
13* 50 54 52 52 54 55 54 B
14 53 64 59 62 62 66 B TO
15* 36 34 35 35 36 37 B TO
16 53 56 54 60 61 61 B N
17* 32 37 34 35 33 38 B PD
18* 45 49 47 50 38 55 C
19 63 69 65 63 69 59 78 C
20* 29 35 32 32 32 17 20 23 34 C PD
21 72 71 72 61 49 53 73 D
22* 55 56 56 50 46 58 D
23* 60 63 62 59 55 52 50 43 D TD
24 54 47 51 50 45 42 41 48 D TO
25* 68 64 66 50 52 49 52 60 57 D TD
* = patients with prior transmural myocardial mfarct.
EX Pattern = see Figure 2 for A, B, C, 0; EXI , EXz, EX], EX. , EXs = left ventricularejection fraction at the end of exercise stage 1,2,3,4
and 5, respectively; IPE = left ventricular ejection fraction immediately after exercise; N = normal; PO = pcrsistmg defect: RI • R, = left ventncular
ejection fractions at rest and at 2 rmnute intervals. respectively; TD = transient defect; TI-201 = thallium-201 scan.
our laboratory. Using the multicrystal gamma camera, count
rates with gold-195m were excellent and, therefore, statis-
tically reliable calculation of left ventricular ejection fraction
was obtained. The correlation between left ventricular ejec-
tion fractions assessed with technetium-99m and gold-195m
was excellent, as was the correlation between repeat gold-
195mstudies. Similar accuracy and reproducibility of gold-
195m first pass studies have been reported by Mena et al.
(6).
The short half-life of gold-195m and the minimal amount
of long-lived mercury-1 95m in the eluate resulted in low
background activity and allowed rapid sequential determi-
nations of left ventricular ejection fraction. In the present
study, individual determinations of left ventricular ejection
fraction during exercise were separated by 3 minutes be-
cause data were obtained at the end of each stage of the
exercise protocol. However. as shown in our study, shorter
time intervals are possible. The multiple repeat studies at
rest and the studies immediately after exercise were per-
formed at I minute intervals and resulted in good quality
studies.
Patient radiation exposure. It is of clinical relevance
that, even when left ventricular performance is determined
during each stage of exercise, the total radiation dose to the
patient is significantly lower than that with a single dose of
the conventional radiotracer technetium-99m. For example,
compared with 20 mCi of technetium-99m, 20 mCi of gold-
195m exposes the kidneys to 5 times less radiation, and the
whole body to 20 times less (1) . The dosimetry using gold-
195m is determined by the breakthrough of the long-lived
parent, mercury-195m. It is essential that each generator be
analyzed for the breakthrough of mercury-195m, because
this determines the maximal number of injections that can
be given in an individual patient. This is a relatively simple
process that can be performed with routine equipment avail-
able in a nuclear medicine radiopharmacy ( J) . In addition,
the long-lived decay product of gold-195m, gold-195 (half-
life = 183 days) can be kept at a minimal level by short
elution intervals « 5 minutes).
First pass and multigated equilibrium angiocardiog-
raphy during exercise. For exercise studies, the first pass
technique offers distinct technical advantages over multi-
gated equilibriumcardiac blood pool imaging. The firstpass
data are acquired over a short period of time and left ven-
tricularejection fraction is derived from 3 to 5 cardiac cycles.
Therefore, first pass left ventricular ejection fractionreflects
more accurately left ventricular function at a distinct point
in time during exercise than multigated equilibrium ejection
lACC Vol. 2. No.3
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Figure 3. Thallium-201 scintigraphy in
Patient 9. An inferoapical perfusion de-
fect (arrow) is present immediately after
exercise. which fills inatdelayed imaging
(redistribution). The images are of good
diagnostic quality . This patient had a total
ofseven first pass studies with gold-195m
during the same exercise test. Two mCi
of thallium-201 was injected during the
second minute of stage 3when thepatient
experienced angina pectoris. Shortly
thereafter, two additional first pass studies
were performed with gold-195m at peak
exercise and during the immediate post-
exercise recovery period before thallium-
201 myocardial imaging was started. ANT
= anterior; LAO = left anterior oblique;
LLAT = left lateral.
REDISTRIBUT ION
. "~~• •••.' ~
ANT LAO LLAT
fraction, which is acquired over several hundreds of heart
beats and represents an "average" value. Because of the
limited count rate capability of conventional single crystal
gamma cameras, the multigated equilibrium technique is
preferred during exercise, and many investigators (7-11)
have shown the clinical usefulness of this approach. Serial
left ventricular ejection fractions during exercise, as per-
formed in the present study with gold-195m, also can be
obtained with technetium-99m using 2 minute multigated
acquisitions. However, these studies frequently have less
than optimal count rate densities in the left ventricular end-
diastolic region of interest. In addition, body motion during
exercise may have a major degrading effect on the quality
of equilibrium blood pool studies, which may be reflected
in poor reproducibility of data processing (12). With the
multigated equlibrium technique, it is possible to obtain
multipleviewsduringrepeatexercisestudies, allowingmore
complete analysis of regional wall motion analysis (13).
This is not readily possible employingtechnetium-99m first
pass studies, but could conceivably be performed using gold-
195m.
Serial left ventricular ejection fraction during exer-
cise. Serial assessment of left ventricular ejection fraction
during various stages of exercise has been reported previ-
ously by Caldwell et al. (8) and others (9-11), using the
multigated equilibriumcardiac blood pool technique. These
investigators observed a similar variability in response to
exercise in patients with coronary artery disease particularly
the " overshoot" of the left ventricular ejection fraction
immediately after exercise. A similar improvement of left
ventricular function, in particular of regional wall motion,
was reported recently by Rosanski et al. (13). Sudden pool-
ing of blood in the capacitance circulation of the legs and
a consequent decrease of left ventricular preload immedi-
ately after termination of upright exercise has been sug-
gested as a possible mechanism for this phenomenon. By
virtue of the heterogeneity of the patients included in the
present study, several different exercise responses were ob-
served. This investigation, however, was not designed to
assess the diagnostic utility of serial ejection fraction de-
termination during exercise but rather its feasibility . The
various patterns observed in this study illustrate the diag-
nostic potential of this approach.
Combined imaging with gold-195m and thallium-
201. The short half-life of gold-195m offers another po-
tentially interesting clinical application. Not only can left
ventricular function be monitored at short time intervals
during various stages of exercise, but simultaneous analysis
of myocardial perfusion using thallium-20l can also be per-
formed. Once the conventional tracer technetium-99m is
administered to a patient, thallium-20 I imaging generally
cannot be performed for at least 24 hours so that technically
acceptable images can be obtained. In the present study,
however, thallium-201 injected at peak exercise could be
imaged without difficulty after discontinuation of exercise,
even after multiple injections of gold-195m (Fig. 3 and 4).
Although gold-195m itself does not effect thallium-20I im-
aging, the breakthroughof mercury-195m in the eluate may
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LAO
Routine After Au-195m Figure 4. Thallium-201 scintigraphy in
Patient 25. Left, Routine thallium-201 (2
mCi) stress test. A stress-induced infer-
oapical defect (arrow) is present. Right,
Thallium-2Ot stress scintigraphy (2 mCi)
after 12 injections of gold- 195m. The pa-
tient exercised to the same work load and
heart rate as during the routine thallium-
20I stress test. Although there is in-
creased background activity from accu-
mulated mercury-195m, the thallium im-
age is of diagnostic quality and shows
again a stress-induced inferoapical defect
(arrow) . LAO = left anterior oblique.
significantly contribute to background activity in the 80 keY
thallium window. The cumulative dose of mercury-195m
after 10 injections, for example, may vary from 50 to 300
J-LCi, which is a relativelysignificant source of radioactivity
compared with the 2 mCi of thallium-201 administered . In
additionto high-energy photons (262 to 560 kev), mercury-
195m also emits low-energy X-rays at 67 to 80 keY (51%).
The background activity from mercury-195m in liver and
kidney is relatively stable over the time periodof initial and
delayed thallium-201 imaging. Therefore, although this ex-
traneoussourceof radioactivity shouldbe considered,quan-
titative analysis of thallium-20 I kinetics should be unaffected.
It is of clinical significance that combined imaging with
gold-195m and thallium-20 I allows assessment of both the
functional response to exerciseand the presenceof exercise-
induced myocardial hypoperfusion, as well as thallium-201
myocardial kinetics, during a single exercise session. Sev-
eral studies(8,14-17) have shownthe complementary value
of performing exercise myocardial perfusion imaging and
left ventricular function studies in patients with coronary
artery disease. By obtaining these studies simultaneously,
this approach may provide a more reliable assessment of
the functional significance of coronary artery stenosis. This
combined technique also has obviousadvantages in relation
to cost effectiveness of patientevaluation, becauseonly one
exercisetest is needed to obtain this information. Even with
the development of new technetium-99m-Iabeled myo-
cardial perfusion imaging agents, this combined approach
wouldbe feasible becauseof the difference in primary pho-
topeak of the radionuclides.
Continuous infusion of gold-195m. Reliable first pass
studies require instruments with high count rate capability
such as the computerized multicrystal gamma camera used
in this study. It is generally agreedthat a conventional single
crystal camera is not optimally suited for first pass studies.
On the other hand, the multicrystal camera is not ideal for
performing thallium-201 myocardial imaging. We previ-
ously demonstrated the feasibility of performing equilib-
rium-gated cardiacbloodpoolstudiesemployingcontinuous
infusion of gold-195m (1,18). This technique could be a
practical alternative when a single crystal camera is being
used for simultaneous assessment of myocardial function
and perfusion at rest and during exercise. The short half-
life of gold-195m also allows rapid alternation of imaging
modes. Discontinuation of continuous infusion of gold-195m
allowsswitching to imagingof a different radioisotope such
as thallium-20 I.
Other short-lived radiotracers. Other short-lived ra-
diotracers that have been proposed recently for first pass
radionuclide angiocardiography include tantalum-178 (half
life = 9.3 minutes) and iridium-199m (half-life = 4.96
seconds). A major limitation of tantalum-I78 for this ap-
plication is the low energy of the major photon emissions
(55 to 65 keY) and high energy background activity (500
keV), which poseproblems for appropriate collimation(19-
20). In contrast, iridium-199m has excellent photon energy
(129 keY) for imaging(21). Treves et al. (22) demonstrated
the feasibility to detect and quantitate left to right cardiac
shunts in infants using this radiotracer. The relatively short
half-life of iridium-199m, which makes it ideally suited for
small children. may be a limitation for application in adults
with longer central circulation time.
Clinical implications. Gold-195m is a new radionuclide
that offers potentially important new clinical applications .
With the expected further technical development of gamma
cameras permitting acquisition of higher count rates, the
first pass technique may well become the method of choice
for performing exercise studies. Consideration will need to
be given to medium-energy collimation, detector shielding
and adequate crystal thickness to maintain both intrinsic
resolution and sensitivity. This radionuclide will not only
decrease patient radiation dose per study, but will also pro-
vide a means of obtaining insight intothe physiologic changes
occurring during exercise or interventions in patients with
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cardiac disease. These physiologic data may have potential
value for the management of these patients. In addition , the
short half-lifeof the radionuclide makes it possible to com-
bine various imaging techniques and obtain simultaneous
information concerning both myocardial function and
perfusion.
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